🇺🇸 FDA
Patent

US 7087582

Combination for site-specifically transforming cells in vivo comprising a double-balloon catheter and nucleic acid comprising a gene encoding P21

granted A61KA61K31/70A61K31/711

Quick answer

US patent 7087582 (Combination for site-specifically transforming cells in vivo comprising a double-balloon catheter and nucleic acid comprising a gene encoding P21) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/70, A61K31/711, A61K38/1709, A61K38/1774